Erasca, Inc.

ERAS ·Healthcare, Drug Manufacturers - General, United States
Financial Statements SEC Filings

SEC Filings

Form Filed Description
8-K Mar 27, 2024 8-K
144 Mar 15, 2024
144 Feb 15, 2024
SC 13G Feb 14, 2024
SC 13G/A Feb 13, 2024 SC 13G/A
4 Feb 7, 2024 FORM 4 SUBMISSION
4 Feb 7, 2024 FORM 4 SUBMISSION
4 Feb 7, 2024 FORM 4 SUBMISSION
4 Feb 7, 2024 FORM 4 SUBMISSION
SC 13D/A Jan 30, 2024 AMENDMENT NO. 3
144 Jan 16, 2024
8-K Jan 9, 2024 8-K
4 Jan 3, 2024 FORM 4 SUBMISSION
4 Jan 3, 2024 FORM 4 SUBMISSION
4 Jan 3, 2024 FORM 4 SUBMISSION
4 Jan 3, 2024 FORM 4 SUBMISSION
4 Jan 3, 2024 FORM 4 SUBMISSION
4 Dec 18, 2023 FORM 4 SUBMISSION
4 Dec 18, 2023 FORM 4 SUBMISSION
144 Dec 15, 2023
8-K Dec 11, 2023 8-K
4 Dec 8, 2023 FORM 4 SUBMISSION
4 Dec 6, 2023 FORM 4 SUBMISSION
4 Dec 4, 2023 FORM 4 SUBMISSION
8-K Nov 28, 2023 8-K
← Newer Page 8 of 14 · 350 filings Older →